BIOMAT Database Logo BIOMAT Database Logo

Complement-mediated lysis with monoclonal antibodies. 1988

J Howard, and N Hughes-Jones

UI MeSH Term Description Entries
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

J Howard, and N Hughes-Jones
Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
October 1988, European journal of immunology,
J Howard, and N Hughes-Jones
Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis.
December 1991, Molecular immunology,
J Howard, and N Hughes-Jones
Inhibition of the classical activation pathway of complement-mediated lysis by monoclonal antibodies to complement components C3c and C3d.
June 1992, Transfusion,
J Howard, and N Hughes-Jones
Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies.
September 1989, Journal of immunology (Baltimore, Md. : 1950),
J Howard, and N Hughes-Jones
Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen. Synergy and interference in complement-mediated lysis.
November 1985, Transplantation,
J Howard, and N Hughes-Jones
Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
January 1991, Complement and inflammation,
J Howard, and N Hughes-Jones
Complement-mediated-lysis detection of antibodies in paracoccidioidomycosis: a preliminary study.
January 1986, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
J Howard, and N Hughes-Jones
Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity.
August 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
J Howard, and N Hughes-Jones
Interactions in the complement-mediated lysis of blood group AB erythrocytes sensitized simultaneously with anti-A and anti-B monoclonal antibodies.
March 1993, Immunology letters,
J Howard, and N Hughes-Jones
Complement mediated lysis in chickens.
January 1982, Developmental and comparative immunology,
Copied contents to your clipboard!